MedTrace Logo

Proton Pump Inhibitor Treatment Stop

NCT00120315 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 171

Last updated 2009-10-06

No results posted yet for this study

Summary

The purpose of this study is to determine how many chronic users of antisecretory medication can stop after a test for a bacteria associated with peptic ulcer disease.

This is evaluated in a discontinuation trial.

Conditions

  • Dyspepsia

Interventions

DRUG

esomeprazole

esomeprazole, original Nexium, 40 mg pills Up to once a day

PROCEDURE

Helicobacter pylori c-13 breath test

Breath test done at entry to find Helicobacter pylori

Sponsors & Collaborators

  • Research Unit of General Practice, Odense

    collaborator OTHER

  • University of Southern Denmark

    collaborator OTHER

  • The Danish Medical Research Council

    collaborator OTHER

  • Apotekerfonden af 1991

    collaborator OTHER

  • AstraZeneca

    collaborator INDUSTRY

  • Danish College of General Practitioners

    collaborator OTHER

  • Odense University Hospital

    lead OTHER

Principal Investigators

  • Ove B Schaffalitzky de Muckadell, Professor · Odense University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-12-31
Primary Completion
2007-03-31
Completion
2007-03-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00120315 on ClinicalTrials.gov